budesonide; formoterol
Generic: BUDESONIDE; FORMOTEROL FUMARATE·Brand: SYMBICORT AEROSPHERE
budesonide; formoterol: developed by 1 company · 1 FDA decision.
budesonide; formoterol evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect budesonide; formoterol to AZN; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could budesonide; formoterol → AZN affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Moderate to Severe COPD
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (2)
| Company | Phase |
|---|---|
| ASTRAZENECA PLC (AZN) | Approved |
| ASTRAZENECA PLC (AZN) Moderate to Severe COPD | Approved |
Frequently asked questions
Who is developing budesonide; formoterol?
budesonide; formoterol is being developed by ASTRAZENECA PLC.
What is budesonide; formoterol's latest FDA decision?
The most recent tracked FDA decision for budesonide; formoterol is Approval, dated April 28, 2023.